Our Services
Medical Information
Helpful Resources
Published on: 9/12/2026
High bilirubin can occur with liver cancer or cirrhosis, but it is far more often caused by other conditions, including gallstones, hepatitis, certain medications, alcohol-related liver injury, or harmless inherited traits like Gilbert syndrome. In advanced cirrhosis or liver tumors that block bile flow, elevated bilirubin may appear alongside jaundice, dark urine, pale stools, swelling in the abdomen or legs, easy bruising, and unexplained weight loss. A single elevated bilirubin result cannot confirm or rule out cancer, and doctors typically look at ALT, AST, ALP, albumin, platelet counts, and imaging before drawing conclusions. There are several important factors that change what an elevated level means, including how high it is, whether it is direct or indirect, and which other results are abnormal, so see below to understand more.
Because the same lab value can point to something minor or something serious, the fastest way to make sense of your situation is to review your full symptom picture rather than one number. A free, instant, online symptom check can help you organize what you are experiencing, surface possible causes, and clarify whether you should seek prompt evaluation or simply follow up at your next appointment.
Last reviewed for medical accuracy: 09/11/2026
Bilirubin is a yellow pigment produced when your body breaks down old red blood cells. Normally, the liver processes bilirubin and sends it to the intestines for elimination. When this system is disrupted, bilirubin levels rise, leading to jaundice (yellowing of skin and eyes) and other symptoms. A blood test measuring total and direct (conjugated) bilirubin helps doctors assess liver function.
What High Bilirubin Indicates
High bilirubin—called hyperbilirubinemia—can point to problems at various stages of bilirubin’s journey:
• Pre-hepatic causes: Excessive red blood cell breakdown (hemolysis)
• Hepatic causes: Impaired liver processing (hepatitis, cirrhosis, genetic disorders)
• Post-hepatic causes: Blocked bile ducts (gallstones, tumors)
Two serious hepatic causes that often raise concern are liver cancer and cirrhosis. Let’s explore how bilirubin behaves in each.
Liver Cancer and Bilirubin
Liver cancer (primary hepatocellular carcinoma) may interfere with the liver’s ability to process and excrete bilirubin:
• Tumor obstruction: Cancerous growths within liver tissue or bile ducts can block bile flow, raising conjugated bilirubin.
• Liver cell damage: Cancer kills healthy hepatocytes, reducing the liver’s capacity to convert unconjugated bilirubin into its water-soluble form.
• Progressive jaundice: In advanced stages, patients may notice worsening yellowing, dark urine, and pale stools.
Key points about liver cancer and bilirubin:
Cirrhosis and Bilirubin
Cirrhosis is the final common pathway of chronic liver injury. Scar tissue replaces healthy liver cells, hampering blood flow and liver function:
• Reduced processing capacity: Scarred liver can’t conjugate bilirubin efficiently, raising unconjugated levels.
• Bile duct distortion: Fibrosis can distort small bile channels, causing cholestasis (bile build-up) and elevated conjugated bilirubin.
• Portal hypertension: Increased pressure in liver blood vessels leads to complications like ascites and variceal bleeding, often accompanying jaundice.
Key points about cirrhosis and bilirubin:
Comparing Liver Cancer vs. Cirrhosis
While both conditions can elevate bilirubin, certain patterns and accompanying signs help distinguish them:
Feature
• Rate of onset
• Accompanying lab changes
• Imaging findings
Liver Cancer
• Bilirubin may rise rapidly if a tumor blocks major bile ducts.
• AFP often elevated; liver enzymes (ALT/AST) may spike unevenly.
• Imaging shows focal masses, vascular invasion, irregular liver contours.
Cirrhosis
• Bilirubin climbs gradually over months to years.
• Low albumin, high INR, low platelets are common.
• Imaging reveals nodular liver surface, signs of portal hypertension (enlarged spleen, varices).
Associated Symptoms
High bilirubin itself causes jaundice, but underlying liver cancer or cirrhosis often bring additional symptoms:
General symptoms of elevated bilirubin:
Symptoms more typical of liver cancer:
Symptoms more typical of cirrhosis:
Other Causes of High Bilirubin
Remember, not all bilirubin elevations mean cancer or cirrhosis. Common non-serious and treatable causes include:
• Gilbert’s syndrome: A harmless genetic condition causing mild unconjugated bilirubin spikes, often during stress or fasting.
• Hemolytic anemias: Conditions like sickle cell or G6PD deficiency that speed up red blood cell breakdown.
• Bile duct stones or strictures: Blockage in bile flow raising conjugated bilirubin.
• Drug-induced liver injury: Certain medications (e.g., acetaminophen overdose, antibiotics) can impair bilirubin processing.
When to Seek Medical Advice
Any persistent or significant rise in bilirubin warrants medical evaluation. Consider next steps if you notice:
You might start with a free, online symptom check, using the doctor approved Ubie Symptom Checker.
What to Expect from Your Doctor
During your visit, your doctor will likely:
Treatments
Treatment depends on the underlying cause:
Key Takeaways
• Bilirubin is a vital indicator of liver and bile duct health.
• High bilirubin can signal liver cancer, cirrhosis, or a range of other conditions.
• Pattern of lab values, symptoms, and imaging guide diagnosis.
• Early evaluation and treatment improve outcomes.
If you experience any serious or life-threatening symptoms—or if bilirubin remains elevated—speak to a doctor without delay.
(References)
* Javitt NB. Cholestatic jaundice. Med Clin North Am. 1975 Jul;59(4):817-21. doi: 10.1016/s0025-7125(16)31977-0. PMID: 1142863.
* Rothuizen J, van den Brom WE, Fevery J. The origins and kinetics of bilirubin in dogs with hepatobiliary and haemolytic diseases. J Hepatol. 1992 May;15(1-2):17-24. doi: 10.1016/0168-8278(92)90006-b. PMID: 1506635.
* O'Reilly SM, Richards MA, Rubens RD. Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer. 1990;26(5):574-7. doi: 10.1016/0277-5379(90)90080-d. PMID: 2144744.
* Maddrey WC, Boitnott JK. Isoniazid hepatitis. Ann Intern Med. 1973 Jul;79(1):1-12. doi: 10.7326/0003-4819-79-1-1. PMID: 4721174.
* Barrett PV. Hyperbilirubinemia of fasting. JAMA. 1971 Sep 6;217(10):1349-53. PMID: 5109641.
* Zawie DA, Garvey MS. Feline hepatic disease. Vet Clin North Am Small Anim Pract. 1984 Nov;14(6):1201-30. doi: 10.1016/s0195-5616(84)50154-5. PMID: 6393553.
* MCPHEDRAN NT, HENDERSON RD. PRURITUS AND JAUNDICE. Can Med Assoc J. 1965 Jun 12;92(24):1258-60. PMID: 14296007; PMCID: PMC1928415.
* Ibrahimi S, Mroué AA, Francois E, Jagodzinski R. Jaundice in a pregnant woman. Acta Gastroenterol Belg. 2017 Jul-Sep;80(3):422-424. PMID: 29560675.
* Xiao X, Chen L, Wu H. Liver Masses. Gastroenterology. 2019 Aug;157(2):e3-e4. doi: 10.1053/j.gastro.2019.03.057. Epub 2019 Apr 5. PMID: 30959031.
* Fujiwara N, Lopez C, Marsh TL, Raman I, Marquez CA, Paul S, Mishra SK, Kubota N, Katz C, Kanzaki H, Gonzalez M, Quirk L, Deodhar S, Selvakumar P, Raj P, Parikh ND, Roberts LR, Schwartz ME, Nguyen MH, Befeler AS, Page-Lester S, Srivastava S, Feng Z, Reddy KR, Khaderi S, Asrani SK, Kanwal F, El-Serag HB, Marrero JA, Singal AG, Hoshida Y. Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis. Gastroenterology. 2025 Mar;168(3):556-567.e7. doi: 10.1053/j.gastro.2024.10.035. Epub 2024 Nov 8. PMID: 39521255; PMCID: PMC7617545.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.